Your Success, Our Support.

Excedr was founded in 2011 by former UC Berkeley students, driven by CEO Jon Chee’s mission to improve how academic labs procure equipment—making it easier to conduct faster, higher-impact research. His belief was simple: better access to equipment would accelerate innovation and, ultimately, lead to better healthcare outcomes for all.

But it quickly became clear that the same challenges existed beyond academia. Biotech and life science companies at every stage were navigating complex R&D and CapEx decisions—often without access to flexible equipment financing. Jon’s time in the lab underscored a broader need: new ways to access capital and fund innovation across the life sciences.

So Excedr expanded. We now support a wide range of organizations—from early- and mid-stage biotechs to publicly traded life science companies, CROs, CMOs, and independent research institutes—helping them acquire the equipment they need without the burdens of purchasing outright.

Today, with 14 years of experience supporting biotech founders, Excedr is a trusted financing partner to some of the most innovative companies in the industry. Our partner network spans research services, software platforms, financial tools, and HR support—because building a life science company takes more than just funding.

We believe helping scientists access critical equipment leads to better technologies, better therapies, and better outcomes. And offering flexible procurement options—without unnecessary equity dilution—can be a powerful advantage in a tough industry.